approved EB-1A
Postdoctoral Fellow
Biomedical Engineering · India · 2021-11-04
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 40 articles in the field of biomedical engineering.
Judging (Met)
The petitioner completed 58 peer reviews for journals of repute.
Original Contributions (Met)
The petitioner's work in nanotechnology and drug delivery systems is supported by 703 citations and major government funding.
Why This Petition Was Approved
The petition was approved based on a record of 40 published articles and 703 citations, demonstrating a high level of influence in the field. Additionally, the petitioner completed 58 peer reviews for reputable journals and received funding from major institutions like the U.S. National Institutes of Health. These metrics satisfied the EB-1A criteria for scholarly articles, judging, and original contributions.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Evidence Submitted
- 40 peer-reviewed articles
- 703 citations
- 58 peer-review assignments for journals of repute
- Funding from India’s Department of Biotechnology
- Funding from the U.S. National Institutes of Health (NIH)
- Expertise in nanotechnology for antiviral ocular devices
Similar Cases
Associate Professor
Healthcare · Canada
WeGreened EB-1A approved
40 days 2026-02-19
The case was approved based on 47 peer-reviewed journal articles and 5 abstracts which garnered 1,369 citations, demonstrating significant independent reliance by the field. Additionally, the petitioner completed 20 peer reviews for selective clinical venues, satisfying the judging and scholarly articles criteria for EB-1A.
Assistant Professor
Research and Development · China
WeGreened EB-1A approved
Florida 16 days 2026-02-18
The case was approved based on a publication record of 33 peer-reviewed articles and 25 completed peer reviews. The petitioner demonstrated extraordinary ability through high citation percentiles, with 10 papers ranked among the most highly cited for their years. Evidence of federal agency support and international reliance across 48 countries satisfied the EB-1A criteria.
Scientist
Research and Development · China
WeGreened EB-1A approved
Washington 20 days 2026-02-09
The petition satisfied EB-1A criteria through a portfolio of 14 journal articles, 6 conference articles, and 17 preprints, which garnered citations from researchers in 42 countries. Additionally, the petitioner completed at least 60 peer reviews for field journals. The evidence demonstrated a systems-level framework for multinode architectures that provides a practical roadmap for modular quantum systems.
Assistant Professor
Engineering · China
WeGreened EB-1A approved
264 days 2026-02-06
The petition was approved based on meeting multiple EB-1A criteria, including influential authorship of 17 journal articles and 2 book chapters, and a strong citation impact of 321 citations. Additionally, the petitioner demonstrated extensive peer-review service with 110 completed reviews and provided evidence of original contributions of major significance to roadway safety and next-generation mobility.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2021-11-04.
Browse all casesAt a Glance
Outcome approved
Processing 30 days
Criteria Met 3 / 3
Evidence Types 7
EB-1A Case Data
Scraped Case Data
Total Cases 937
Success Rate 53.9%
Sustained 505
Dismissed 315
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist